Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00810147
What this trial is testing

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 209
Testing effectiveness (Phase 2)Study completedNCT06423352
What this trial is testing

Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

Who this might be right for
Mild to Moderate Hypertension
Alnylam Pharmaceuticals 36
Early research (Phase 1)Study completedNCT00019838
What this trial is testing

UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01301508
What this trial is testing

Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 46
Large-scale testing (Phase 3)Study completedNCT04158648
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Who this might be right for
Mild Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHemophilia A
Hoffmann-La Roche 73
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT07269457
What this trial is testing

Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT)

Who this might be right for
Traumatic Brain Injury (TBI) PatientsNeuroinflammation
Lagos State University 240
Testing effectiveness (Phase 2)Study completedNCT00690937
What this trial is testing

A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia

Who this might be right for
Hypercholesterolemia
Genzyme, a Sanofi Company 120
Testing effectiveness (Phase 2)Study completedNCT00734292
What this trial is testing

Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma

Who this might be right for
Mild to Moderate Asthma
SkyePharma AG 39
Not applicableStudy completedNCT06732830
What this trial is testing

Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop

Who this might be right for
Dry Eye Syndrome
i+Med S.Coop. 45
Testing effectiveness (Phase 2)Study completedNCT02493712
What this trial is testing

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Who this might be right for
Colitis, Ulcerative
Holy Stone Healthcare Co., Ltd 51
Testing effectiveness (Phase 2)Ended earlyNCT03919175
What this trial is testing

Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma

Who this might be right for
LymphomaFollicular LymphomaFollicular Lymphoma, Grade 1+4 more
Massachusetts General Hospital 18
Early research (Phase 1)Study completedNCT00442871
What this trial is testing

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Study completedNCT03392168
What this trial is testing

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Arcutis Biotherapeutics, Inc. 91
Not applicableStudy completedNCT02007291
What this trial is testing

Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment

Who this might be right for
Late Onset Alzheimer
Federal University of Minas Gerais 71
Large-scale testing (Phase 3)Study completedNCT01045018
What this trial is testing

A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis

Who this might be right for
Mild to Moderate Ulcerative Colitis
EMET Pharmaceuticals, LLC
Testing effectiveness (Phase 2)Ended earlyNCT05124210
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 8
Post-approval studies (Phase 4)Study completedNCT00473174
What this trial is testing

Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension

Who this might be right for
Hypertension
University of Vigo 120
Early research (Phase 1)Ended earlyNCT00785551
What this trial is testing

Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment

Who this might be right for
HealthyRenal Impairment
Mutual Pharmaceutical Company, Inc. 5
Early research (Phase 1)Study completedNCT03192111
What this trial is testing

Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Volunteer
Syndax Pharmaceuticals 40
Next Page